Latest / Mind Meets Machine: Global
Signals with Purpose: Reza Khanbabaie on Seizure Prediction, Pharma-Backed Innovation and Patient-Centred Neurotech
I sat down with Reza Khanbabaie a former founder and CEO with over 20 peer-reviewed papers and four patents, who has spent 25 years turning brain signals into technology for patients. Today he is at Mentis Care AI, building AI to detect and predict seizures for people living with epilepsy.
A few insights that stood out:
🔹 Who backs you shapes what you build. Mentis Care AI is pharma-backed rather than venture-backed. A backer that knows the patient population helps you avoid costly mid-course changes in design and strategy, and gives the work a clearer long-term direction.
🔹 Clinical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.